Wynette Almeida
Adult Health · New York, NYNPI 1518550268
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,744 of the $4,343 with a category attached, or 86.2%. It is spread thinly across 30 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,521 and has fallen 63.6% since, to $553 in 2025. Among adult health clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 123 payments — averaging $35.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$663
- Daiichi Sankyo Inc.$428
- Eisai Inc.$363
- Seagen Inc.$314
- Pfizer$286
- AVEO Pharmaceuticals, Inc.$269
- plus $2K from 24 others
What the payments were for
- Food & beverage$3,74486%
- Education$59914%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 15 | $663 |
| Daiichi Sankyo Inc. | 9 | $428 |
| Eisai Inc. | 17 | $363 |
| Seagen Inc. | 7 | $314 |
| Pfizer | 11 | $286 |
| AVEO Pharmaceuticals, Inc. | 6 | $269 |
| AbbVie | 2 | $258 |
| AstraZeneca | 6 | $236 |
| Merck | 10 | $206 |
| Sanofi-aventis U.S. LLC | 2 | $199 |
| Tolmar Pharmaceuticals, Inc. | 4 | $195 |
| Foundation Medicine, Inc. | 2 | $138 |
| Bayer | 6 | $130 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $119 |
| Dendreon Pharmaceuticals LLC | 3 | $76 |
| Sanofi | 2 | $72 |
| Myovant Sciences Inc. | 4 | $70 |
| E.r. Squibb & Sons, L.L.C. | 2 | $40 |
| Novartis | 2 | $33 |
| Gilead | 1 | $31 |
| Astellas Pharma US Inc | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Puma Biotechnology, Inc. | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| Bristol Myers Squibb | 1 | $23 |
| Immunogen, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $22 |
| Tersera Therapeutics LLC | 1 | $22 |
| EMD Serono, Inc. | 1 | $22 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Enhertu$273
- EPKINLY$142
- ELIGARD$137
- LYNPARZA$125
- FOTIVDA$122
- DARZALEX$120
- TECVAYLI$120
- Erleada$120
- FOUNDATIONONE$117
- FOUNDATIONONE HEME$117
- FOUNDATIONONE CDX$117
- FOUNDATIONFOCUS$117
- FOUNDATIONONE LIQUID CDX$117
How this compares
$4,343 in reported general payments places this provider in the 90th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abiraterone Acetate | 17 | $11,628 |
| Oxycodone Hcl | 12 | $171 |
| Ondansetron OdtOndansetron | 15 | $93 |
| Tamsulosin Hcl | 13 | $75 |
Paid to pharmacies, not to this prescriber.
Other adult health in New York
- Donna CatameroNew York$279K
- Alyson HartyNew York$65K
- Laura GraaflandNew York$51K
- Allysa SaggeseNew York$49K
- Juliet EscalonNew York$46K
- Teshmanie RampersaudNew York$23K
- Elizabeth SavageNew York$20K
- Libby LevineNew York$19K
- Hyo Jin KangNew York$19K
- Monica RicheyNew York$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.